Saturday, February 28, 2015

FDA Allows Direct-To-Consumer Genetic Tests

One year after a very public squabble with genetic-testing company 23andMe, the Food and Drug Administration has decided not only to allow 23andMe to directly market its genetic test to consumer as a diagnostic device, but to free other genetic-testing companies from pre-market review or prescription status.

Read the entire column at NCPA's Health Policy Blog.

No comments: